Abstract
The introduction of a new drug in the treatment of a disease or a group of disorders often rises a widespread optimism. Unfortunately, with increasing experience, the optimism very often turns to deep scepticism, especially, when serious side effects occur. The application of corticosteroids in the treatment of rheumatoid arthritis is a typical example of the fact just mentioned.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hench, P. S., Kendall, E. C, Ulocumb, C. H., Polley, H. F.: The effect of a hormone of the adrenal cortex (17-hydroxy-ll-dehydrocorticosterone: compound E) and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis. Proc. Mayo Clin. 24, 181 (1949).
Steinbrocker, O., Traeger, C. H., Battermann, R. C.: Therapeutic criteria in rheumatoid arthritis. J. Amer. med. Ass. 140, 659 (1949).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Drivsholm, A., Boye-Nielsen, J., Brøchner-Mortensen, K. (1974). Long-Term Treatment with Corticosteroids in Rheumatoid Arthritis over a Period of 19 to 22 Years. In: Tanner, E. (eds) Annals of Life Insurance Medicine 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65844-0_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-65844-0_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65846-4
Online ISBN: 978-3-642-65844-0
eBook Packages: Springer Book Archive